Generic Name and Formulations:
Acarbose 25mg, 50mg, 100mg; tabs.
Indications for PRECOSE:
Adjunct to diet in type 2 diabetes, alone or with insulin, metformin, or a sulfonylurea.
Take with first bite of each main meal. Initially 25mg three times daily; increase at 4–8 wk intervals if needed. Or, (to minimize GI effects): initially 25mg once daily, increase gradually to 25mg three times daily. Range: 50–100mg three times daily. ≤60kg: max 50mg three times daily; >60kg: max 100mg three times daily.
Ketoacidosis. Cirrhosis. Inflammatory bowel disease. Colonic ulceration. Partial or predisposition to intestinal obstruction. Chronic intestinal disease with marked disorders of digestion or absorption. Conditions that may deteriorate from increased intestinal gas formation.
Significant renal dysfunction (serum creatinine >2mg/dL): not recommended. Use glucose, not sucrose, to treat hypoglycemia. Stress. Monitor 1-hour postprandial glucose initially and during titration, then glycosylated hemoglobin. Monitor serum transaminases every 3 months during 1st year and periodically thereafter. Pregnancy (Cat.B): consider insulin instead. Nursing mothers: not recommended.
Caution with drugs that cause hyperglycemia (eg, diuretics, steroids, estrogens, phenothiazines, thyroid products, phenytoin, niacin, sympathomimetics, calcium channel blockers, isoniazid). Antagonized by intestinal adsorbents (eg, charcoal), pancreatin, amylase, other carbohydrate-splitting enzymes. Monitor digoxin; and for hypoglycemia if used with insulin or a sulfonylurea. May result in unreliable measurements of 1,5-AG assay; use alternative methods to monitor glycemic control.
Transient flatulence, diarrhea, abdominal pain.
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments